معرفی
Hans M. Dalton is an Assistant Professor in the Department of Molecular Biosciences at the University of Kansas. His research focuses on essential genes and their role in rare human diseases, particularly Congenital Disorders of Glycosylation (CDGs). He employs Drosophila models and FDA-approved drug repurposing screens to identify therapeutic interventions. Dalton's work bridges basic science and translational medicine, leveraging genetic conservation between model organisms and humans.
- Education: Ph.D. in Molecular Biology (University of Southern California, 2018), Postdoctoral Research in Human Genetics (University of Utah, 2024), B.S. in Biochemistry (University of Michigan, 2012)
Research interests center on essential gene biology, rare disease mechanisms, drug repurposing, and aging-related gene inhibition. His lab utilizes advanced techniques including CRISPR screens, Drosophila genetics, and metabolomics to explore disease pathways and therapeutic opportunities.
Scientific awards include the K99/R00 transition grant from NICHD. Publications highlight his work on CDGs, ER stress, and conserved gene functions in C. elegans and Drosophila. His lab opened in August 2024, welcoming graduate student Mandi Wild and assistant researchers Viet Le and KJ Pittman.
